A Cost-Effectiveness Analysis for Avelumab as a First-Line Maintenance Treatment of Advanced Urothelial Carcinoma in the Netherlands
在荷兰，一项关于阿维鲁单抗作为晚期尿路上皮癌一线维持治疗的成本效益分析
期刊:Oncology and Therapy
影响因子:3.2
doi:10.1007/s40487-025-00345-3
Smalbrugge, David; Walsteijn, Tim; de Feijter, Jeantine; Suelmann, Britt; Kearney, Mairead; Benedict, Agnes; Kapetanakis, Venediktos; van Beekhuizen, Sophie
